Cisplatin binding to human serum albumin: a structural study
about
Structural evidences for a secondary gold binding site in the hydrophobic box of lysozymeCisplatin encapsulation within a ferritin nanocage: a high-resolution crystallographic studyEffect of temperature on the interaction of cisplatin with the model protein hen egg white lysozymeMapping the protein-binding sites for iridium(iii)-based CO-releasing moleculesCirculatory zinc transport is controlled by distinct interdomain sites on mammalian albumins.Interactions of cisplatin analogues with lysozyme: a comparative analysis.Exploring the activity of a polyazine bridged Ru(ii)-Pt(ii) supramolecule in F98 rat malignant glioma cells.Pyrithione-based ruthenium complexes as inhibitors of aldo-keto reductase 1C enzymes and anticancer agents.Exploring Intein Inhibition by Platinum Compounds as an Antimicrobial Strategy.X-ray Structure Analysis of Indazolium trans-[Tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019) Bound to Human Serum Albumin Reveals Two Ruthenium Binding Sites and Provides Insights into the Drug Binding Mechanism.Megalin Blockade with Cilastatin Suppresses Drug-Induced Nephrotoxicity.Organometallic cobalamin anticancer derivatives for targeted prodrug delivery via transcobalamin-mediated uptake.Structure of in cell protein crystals containing organometallic complexes.Prediction of the interaction of metallic moieties with proteins: An update for protein-ligand docking techniques.Protein metalation by metal-based drugs: X-ray crystallography and mass spectrometry studies.Principles and methods used to grow and optimize crystals of protein-metallodrug adducts, to determine metal binding sites and to assign metal ligands.Cisplatin Binding to Biological Ligands Revealed at the Encounter Complex Level by IR Action Spectroscopy.Protein Metalation by Anticancer Metallodrugs: A Joint ESI MS and XRD Investigative Strategy.HSA-based multi-target combination therapy: regulating drugs' release from HSA and overcoming single drug resistance in a breast cancer model.The Development of a Nano-based Approach to Alleviate Cisplatin-Induced Ototoxicity.X-ray Structure of the Carboplatin-Loaded Apo-Ferritin Nanocage.Captopril apparently increase and cisplatin apparently decrease human albumin concentration in artificial urinary solutions.Insonation of Systemically Delivered Cisplatin-Loaded Microbubbles Significantly Attenuates Nephrotoxicity of Chemotherapy in Experimental Models of Head and Neck Cancer
P2860
Q27700978-E9299037-7B9E-4D49-85AA-5A851E648FCFQ27704043-A1116106-BE0B-48E0-8528-794B99C7E520Q27704513-66C6AE05-A42C-4869-8E9A-265064AA6748Q27719016-809BC694-FFBF-46FA-9AC5-B8C99E21E57CQ30252235-0F78BDF6-EDC4-4353-BC9D-BB691E962903Q38624654-05B85975-82AA-43EA-A840-29A3F12AC6B9Q38728302-4E72E90A-2C0F-4FB2-BFDE-5E30A8BBFBC1Q38760811-2822168C-E1B3-43BB-B9B3-F81A0A44ECD8Q38823110-6766D19A-3CF5-4E6D-BE29-F6F3FB55BB80Q39753526-9A6BFBF5-FD6F-489C-895A-0568701A9C1FQ40385407-2F417DDF-04BC-4C91-9DE6-9EF7CEAD72EDQ46427814-CEE6E029-5144-4E99-977C-D17347EF30E5Q47401567-CA9FFE70-81CC-4F9C-AED7-480D23703F0AQ47596686-B97DC917-95DD-40F1-BEE9-13FC228CF489Q47667663-99DB91EF-4E72-4F6D-A1BC-E728EA2F1F57Q47717493-F1410D60-7940-4078-8070-59D0BA43D916Q48265802-F960FA51-BBCE-4A32-9FC9-A0EB1EA162EFQ48368172-3D29D70D-F1EC-43EA-82AF-5BC70605BD4EQ49928163-82E41848-ED84-40A0-BE2E-6AE2D31F0F1EQ49936568-DE9726A0-3056-48E4-8E99-933F1EC0BAFEQ50905102-12A92087-227E-49F8-AD79-19A506B5B14FQ50997729-D0A68681-DE51-41A3-82F7-B9F494DC5D94Q58762549-39E9B00A-66D0-4708-B909-BB6253FC3EE8
P2860
Cisplatin binding to human serum albumin: a structural study
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Cisplatin binding to human serum albumin: a structural study
@ast
Cisplatin binding to human serum albumin: a structural study
@en
Cisplatin binding to human serum albumin: a structural study
@nl
type
label
Cisplatin binding to human serum albumin: a structural study
@ast
Cisplatin binding to human serum albumin: a structural study
@en
Cisplatin binding to human serum albumin: a structural study
@nl
prefLabel
Cisplatin binding to human serum albumin: a structural study
@ast
Cisplatin binding to human serum albumin: a structural study
@en
Cisplatin binding to human serum albumin: a structural study
@nl
P3181
P356
P1476
Cisplatin binding to human serum albumin: a structural study
@en
P2093
Lara Massai
Luigi Messori
P304
P3181
P356
10.1039/C5CC01751C
P407
P577
2015-06-11T00:00:00Z